We are live on ! Find out more
Nisa Investment Advisors

Nisa Investment Advisors Portfolio holdings

AUM $27B
1-Year Est. Return 24.49%
This Fund
S&P 500
This Quarter Est. Return
+10.4%
1 Year Est. Return
+24.49%
3 Year Est. Return
+88.53%
5 Year Est. Return
+114.58%
10 Year Est. Return
+419.26%
AUM
$13.3B
AUM Growth
+$13.3B
Cap. Flow
+$572M
Cap. Flow %
4.29%
Top 10 Hldgs %
21.46%
Holding
2,413
New
103
Increased
497
Reduced
1,007
Closed
275

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$303M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$301M
3
NVDA icon
NVIDIA
NVDA
+$58.2M
4
NTES icon
NetEase
NTES
+$50.8M
5
JD icon
JD.com
JD
+$47.5M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$44M
2
MSFT icon
Microsoft
MSFT
+$40.2M
3
NKE icon
Nike
NKE
+$33.1M
4
DOCU
DocuSign
DOCU
+$21.8M
5
V icon
Visa
V
+$20.1M

Sector Composition

Rank Sector Weight
1 Technology 19.03%
2 Healthcare 12.16%
3 Financials 11.56%
4 Communication Services 9.83%
5 Consumer Discretionary 8.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RUBY
2101
DELISTED
Rubius Therapeutics, Inc
RUBY
$5K ﹤0.01%
800
AERI
2102
DELISTED
Aerie Pharmaceuticals
AERI
$5K ﹤0.01%
700
-7,883
-92% -$82.5K
CVM icon
2103
CEL-SCI Corp
CVM
$30.1M
$4K ﹤0.01%
20
EGBN icon
2104
Eagle Bancorp
EGBN
$845M
$4K ﹤0.01%
70
LAB icon
2105
Standard BioTools
LAB
$314M
$4K ﹤0.01%
1,335
PGEN icon
2106
Precigen
PGEN
$2.59B
$4K ﹤0.01%
1,477
-80,000
-98% -$344K
EVBG
2107
DELISTED
Everbridge, Inc. Common Stock
EVBG
$4K ﹤0.01%
85
-200
-70% -$24.2K
ADPT icon
2108
Adaptive Biotechnologies
ADPT
$3.97B
$3K ﹤0.01%
158
-217
-58% -$6.65K
AVTX icon
2109
Avalo Therapeutics
AVTX
$983M
$3K ﹤0.01%
1
COIN icon
2110
Coinbase
COIN
$40.5B
$3K ﹤0.01%
+14
New +$4.07K
DYN icon
2111
Dyne Therapeutics
DYN
$4.9B
$3K ﹤0.01%
347
-477
-58% -$6.7K
ELUT icon
2112
Elutia
ELUT
$37.6M
$3K ﹤0.01%
547
-753
-58% -$4.41K
FIVE icon
2113
Five Below
FIVE
$13.5B
$3K ﹤0.01%
21
GRWG icon
2114
GrowGeneration
GRWG
$90.7M
$3K ﹤0.01%
350
IHT
2115
InnSuites Hospitality Trust
IHT
$16M
$3K ﹤0.01%
972
MRSN
2116
DELISTED
Mersana Therapeutics
MRSN
$3K ﹤0.01%
24
OCUL icon
2117
Ocular Therapeutix
OCUL
$2.02B
$3K ﹤0.01%
500
UVE icon
2118
Universal Insurance Holdings
UVE
$1.23B
$3K ﹤0.01%
200
-3,400
-94% -$51.4K
AY
2119
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
$3K ﹤0.01%
85
CLVS
2120
DELISTED
Clovis Oncology, Inc.
CLVS
$3K ﹤0.01%
1,345
MIC
2121
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$3K ﹤0.01%
720
-10,100
-93% -$66K
ECOL
2122
DELISTED
US Ecology, Inc.
ECOL
$3K ﹤0.01%
100
-600
-86% -$19.8K
ADVM
2123
DELISTED
Adverum Biotechnologies
ADVM
$2K ﹤0.01%
103
LONA
2124
LeonaBio Inc
LONA
$72.1M
$2K ﹤0.01%
24
-32
-57% -$4.05K
CHGG icon
2125
Chegg
CHGG
$102M
$2K ﹤0.01%
65
-1,900
-97% -$77.1K

Similar funds

Nisa Investment Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Nisa Investment Advisors held 2,413 positions worth $13.3B, up 80,795% from $16.5M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Nisa Investment Advisors deployed $572M of net new capital in Q4 2021, opening 103 new positions and adding to 497 existing holdings. Its largest new stake was iShares Core S&P 500 ETF: 657,000 shares worth $297M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $44M trimmed.

  • Nisa Investment Advisors's largest Q4 2021 buy was iShares Core S&P 500 ETF: 657,000 shares worth $297M.
  • Nisa Investment Advisors added most to NVIDIA in Q4 2021, an estimated $58.2M increase.
  • Nisa Investment Advisors's biggest Q4 2021 reduction was Meta Platforms (Facebook), cutting an estimated $44M.
  • Nisa Investment Advisors fully exited Apple in Q4 2021, selling an estimated $753K.
  • Nisa Investment Advisors's ten largest holdings make up 21% of its $13.3B portfolio in Q4 2021.
  • Nisa Investment Advisors opened 103 new positions and closed 275 in Q4 2021.
  • Nisa Investment Advisors's portfolio value rose 80,795% quarter-over-quarter to $13.3B.

Based on Nisa Investment Advisors's 13F filing for Q4 2021, filed 3 Feb 2022.